Supplementary publication 2/2015 - Official Journal EPO

Online publication date: 20.3.2015
CASE LAW FROM THE CONTRACTING STATES TO THE EPC
Contents
Foreword  
Acknowledgments 
Table of Cases 
I. PATENTABILITY
A. Article 52 EPC – Patentable inventions
 
1. Technical character
 
2. Excluded subject-matter and activities
 
2.1 Discoveries
 
2.2 Computer programs
 
B. Exceptions to patentability
 
1. Breaches of "ordre public" or morality
 
2. Biological inventions
 
C. Novelty
 
1. State of the art
 
2. Chemical inventions
 
3. Novelty of use – Article 54(5) EPC
 
D. Inventive step
 
1. Assessment of inventive step
 
2. Problem-solution approach
 
3. Technical effect
 
4. Skilled person
 
E. Industrial applicability
 
F. Double patenting
 
II. SUFFICIENCY OF DISCLOSURE
III. CLAIMS
A. Clarity of claims
 
B. Interpretation of claims and extent of protection
 
C. Independent and dependent claims
 
D. Amendments to claims
 
IV. PRIORITY
V. EUROPEAN PATENTS SUBJECT TO LITIGATION IN MULTIPLE JURISDICTIONS
1. Danisco/Novozymes (EP 1 804 592)
 
2. Quetiapine (EP 0 907 364)
 
3. Olanzapine (EP 0 454 436)
 
4. Occlusion device (EP 0 808 138)
 
5. Calcipotriol (EP 0 679 154)
 
6. St Gobain/Knauf (EP 0 399 320)
 
VI. INSTITUTIONAL MATTERS
1. Judicial status of the EPO Boards of Appeal
 
2. EPO decisions, the Convention and national courts
 
3. Stay of national proceedings
 
4. Reservation to the EPC: scope of the Spanish reservation under Article 167(2)(a) EPC 1973
 

 

Quick Navigation